Sohel H, Kiyono T, Zahan U, Razia S, Ishikawa M, Yamashita H
Int J Mol Sci. 2025; 26(5).
PMID: 40076621
PMC: 11901000.
DOI: 10.3390/ijms26051995.
Bai J, Yang G, Yu Q, Chi Q, Zeng X, Qi W
Front Oncol. 2025; 15:1535929.
PMID: 40071088
PMC: 11893431.
DOI: 10.3389/fonc.2025.1535929.
Motamed R, Jabbari K, Sheikhbahaei M, Ghazimoradi M, Ghodsi S, Jahangir M
Sci Rep. 2025; 15(1):6593.
PMID: 39994414
PMC: 11850621.
DOI: 10.1038/s41598-025-91314-3.
Zhang J, Zhang J, Yang C
J Transl Med. 2025; 23(1):52.
PMID: 39806481
PMC: 11727735.
DOI: 10.1186/s12967-024-06063-0.
Mirzaei N, Hur C, Terry M, Dalerba P, Yang W
medRxiv. 2024; .
PMID: 39677417
PMC: 11643252.
DOI: 10.1101/2024.12.05.24318584.
Comprehensive whole-genome sequencing reveals origins of mutational signatures associated with aging, mismatch repair deficiency and temozolomide chemotherapy.
Hwang T, Sitko L, Khoirunnisa R, Navarro-Aguad F, Samuel D, Park H
Nucleic Acids Res. 2024; 53(1.
PMID: 39656916
PMC: 11724276.
DOI: 10.1093/nar/gkae1122.
A four-hit mechanism is sufficient for meningioma development.
Devarajan A, Seah C, Zhang J, Vasan V, Feng R, Chapman E
J Neurooncol. 2024; 171(3):599-607.
PMID: 39586894
DOI: 10.1007/s11060-024-04877-y.
Deletions Rate-Limit Breast and Ovarian Cancer Initiation.
Houlahan K, Bihie M, Contreras J, Fulop D, Lopez G, Huang H
bioRxiv. 2024; .
PMID: 39484366
PMC: 11526986.
DOI: 10.1101/2024.10.17.618945.
Accumulation of Oncogenic Mutations During Progression from Healthy Tissue to Cancer.
Zhang R, Bozic I
Bull Math Biol. 2024; 86(12):142.
PMID: 39472320
PMC: 11522190.
DOI: 10.1007/s11538-024-01372-3.
An evaluation of trends for mesothelioma mortality in American women: Addressing the content of a recent Morbidity and Mortality Weekly Report (MMWR).
Stevens M, Tuttle B, Brew D, Paustenbach D
Toxicol Ind Health. 2024; 41(1):40-60.
PMID: 39447016
PMC: 11626854.
DOI: 10.1177/07482337241293201.
When Do Tumours Develop? Neoplastic Processes Across Different Timescales: Age, Season and Round the Circadian Clock.
Bieuville M, Dujon A, Raven N, Ujvari B, Pujol P, Eslami-S Z
Evol Appl. 2024; 17(10):e70024.
PMID: 39444444
PMC: 11496201.
DOI: 10.1111/eva.70024.
Multistage carcinogenesis in occupational cholangiocarcinoma: the impact of clonal expansion and risk estimation.
Watanabe M, Haeno H, Mimaki S, Tsuchihara K
Genes Environ. 2024; 46(1):21.
PMID: 39444007
PMC: 11515581.
DOI: 10.1186/s41021-024-00315-7.
Ras, RhoA, and vascular pharmacology in neurodevelopment and aging.
Nussinov R, Jang H, Cheng F
Neurochem Int. 2024; 181:105883.
PMID: 39427854
PMC: 11614691.
DOI: 10.1016/j.neuint.2024.105883.
Hydrogel-based platforms for site-specific doxorubicin release in cancer therapy.
Zang C, Tian Y, Tang Y, Tang M, Yang D, Chen F
J Transl Med. 2024; 22(1):879.
PMID: 39350207
PMC: 11440768.
DOI: 10.1186/s12967-024-05490-3.
56Fe-ion Exposure Increases the Incidence of Lung and Brain Tumors at a Similar Rate in Male and Female Mice.
Finkelstein S, Patel R, Deland K, Mercer J, Starr B, Zhu D
Radiat Res. 2024; 202(5):734-744.
PMID: 39307527
PMC: 11608577.
DOI: 10.1667/RADE-24-00004.1.
CDMPred: a tool for predicting cancer driver missense mutations with high-quality passenger mutations.
Wang L, Sun H, Yue Z, Xia J, Li X
PeerJ. 2024; 12:e17991.
PMID: 39253604
PMC: 11382650.
DOI: 10.7717/peerj.17991.
Association of Mutation and Gene Pathways in Colorectal Carcinoma: A Transcriptome- and Methylome-Wide Study and Potential Implications for Therapy.
Jasmine F, Almazan A, Khamkevych Y, Bissonnette M, Ahsan H, Kibriya M
Int J Mol Sci. 2024; 25(15).
PMID: 39125664
PMC: 11311678.
DOI: 10.3390/ijms25158094.
Review: Cancer and neurodevelopmental disorders: multi-scale reasoning and computational guide.
Nussinov R, Yavuz B, Demirel H, Arici M, Jang H, Tuncbag N
Front Cell Dev Biol. 2024; 12:1376639.
PMID: 39015651
PMC: 11249571.
DOI: 10.3389/fcell.2024.1376639.
Single cell spatial biology over developmental time can decipher pediatric brain pathologies.
Nussinov R, Yavuz B, Jang H
Neurobiol Dis. 2024; 199:106597.
PMID: 38992777
PMC: 11286356.
DOI: 10.1016/j.nbd.2024.106597.
Mitogen signaling strength and duration can control cell cycle decisions.
Nussinov R, Zhang W, Liu Y, Jang H
Sci Adv. 2024; 10(27):eadm9211.
PMID: 38968359
PMC: 11809619.
DOI: 10.1126/sciadv.adm9211.